Khalil Abou‐El‐Ardat

1.6k total citations · 1 hit paper
21 papers, 1.0k citations indexed

About

Khalil Abou‐El‐Ardat is a scholar working on Molecular Biology, Genetics and Cancer Research. According to data from OpenAlex, Khalil Abou‐El‐Ardat has authored 21 papers receiving a total of 1.0k indexed citations (citations by other indexed papers that have themselves been cited), including 8 papers in Molecular Biology, 8 papers in Genetics and 7 papers in Cancer Research. Recurrent topics in Khalil Abou‐El‐Ardat's work include Acute Myeloid Leukemia Research (5 papers), Glioma Diagnosis and Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Khalil Abou‐El‐Ardat is often cited by papers focused on Acute Myeloid Leukemia Research (5 papers), Glioma Diagnosis and Treatment (4 papers) and Hemoglobinopathies and Related Disorders (4 papers). Khalil Abou‐El‐Ardat collaborates with scholars based in Germany, Belgium and Netherlands. Khalil Abou‐El‐Ardat's co-authors include Sebastian Wagner, Michael A. Rieger, Tina Rasper, Andreas M. Zeiher, Birgit Aßmus, Stefanie Dimmeler, Lena Dorsheimer, Florian Seeger, Jedrzej Hoffmann and Hubert Serve and has published in prestigious journals such as PLoS ONE, Oncogene and The FASEB Journal.

In The Last Decade

Khalil Abou‐El‐Ardat

21 papers receiving 1.0k citations

Hit Papers

align trajectories sort by overperformance

What are hit papers?

Hit papers significantly outperform the citation benchmark for their cohort. A paper qualifies if it has ≥500 total citations, achieves ≥1.5× the top-1% citation threshold for papers in the same subfield and year (this is the minimum needed to enter the top 1%, not the average within it), or reaches the top citation threshold in at least one of its specific research topics.

Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure

2018 326 citations Lena Dorsheimer, Birgit Aßmus et al. JAMA Cardiology profile →

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name	h						Papers	Cites
Khalil Abou‐El‐Ardat Germany	16	371	339	329	171	149	21	1.0k
Marjolein Kerver Netherlands	10	339 0.9×	160 0.5×	410 1.2×	116 0.7×	98 0.7×	12	1.2k
Floris P. J. van Alphen Netherlands	18	481 1.3×	181 0.5×	227 0.7×	118 0.7×	206 1.4×	47	1.3k
Abhishek Niroula Sweden	20	653 1.8×	462 1.4×	640 1.9×	199 1.2×	78 0.5×	45	1.5k
Elizabeth A. Traxler United States	10	547 1.5×	214 0.6×	424 1.3×	45 0.3×	210 1.4×	15	1.2k
Serine Avagyan United States	12	378 1.0×	118 0.3×	274 0.8×	155 0.9×	132 0.9×	27	1.0k
Maya N. Polackal United States	6	412 1.1×	394 1.2×	580 1.8×	129 0.8×	47 0.3×	7	1.2k
Eric M. Bindels Netherlands	23	984 2.7×	275 0.8×	517 1.6×	199 1.2×	238 1.6×	75	1.7k
Ruben Bierings Netherlands	21	467 1.3×	130 0.4×	570 1.7×	66 0.4×	70 0.5×	55	1.3k
Qin Zen United States	9	312 0.8×	232 0.7×	246 0.7×	133 0.8×	352 2.4×	10	961
Dusten Unruh United States	13	215 0.6×	172 0.5×	105 0.3×	89 0.5×	177 1.2×	20	661

Countries citing papers authored by Khalil Abou‐El‐Ardat

Since Specialization

Citations

This map shows the geographic impact of Khalil Abou‐El‐Ardat's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Khalil Abou‐El‐Ardat with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Khalil Abou‐El‐Ardat more than expected).

Fields of papers citing papers by Khalil Abou‐El‐Ardat

Since Specialization

Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Khalil Abou‐El‐Ardat. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Khalil Abou‐El‐Ardat. The network helps show where Khalil Abou‐El‐Ardat may publish in the future.

Co-authorship network of co-authors of Khalil Abou‐El‐Ardat

This figure shows the co-authorship network connecting the top 25 collaborators of Khalil Abou‐El‐Ardat. A scholar is included among the top collaborators of Khalil Abou‐El‐Ardat based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Khalil Abou‐El‐Ardat. Khalil Abou‐El‐Ardat is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

Sort: Min cites: Since: Top N: Style:

20 of 20 papers shown

Polat, Ibrahim H., Khalil Abou‐El‐Ardat, Islam Alshamleh, et al.. (2021). Metabolic Rewiring Is Essential for AML Cell Survival to Overcome Autophagy Inhibition by Loss of ATG3. Cancers. 13(23). 6142–6142. 6 indexed citations

Oppermann, Elsie, Khalil Abou‐El‐Ardat, Thomas Oellerich, et al.. (2021). Transglutaminase 2 promotes tumorigenicity of colon cancer cells by inactivation of the tumor suppressor p53. Oncogene. 40(25). 4352–4367. 26 indexed citations

Cremer, Sebastian, Evangelia Pardali, Birgit Aßmus, et al.. (2021). Full Spectrum of Clonal Haematopoiesis-Driver Mutations in Chronic Heart Failure and their Associations with Mortality. ESC Heart Failure. 8(3). 1873–1884. 31 indexed citations

Michels, Birgitta E., Mohammed H. Mosa, Tianzuo Zhan, et al.. (2020). Pooled In Vitro and In Vivo CRISPR-Cas9 Screening Identifies Tumor Suppressors in Human Colon Organoids. Cell stem cell. 26(5). 782–792.e7. 170 indexed citations

Aßmus, Birgit, Sebastian Cremer, Klara Kirschbaum, et al.. (2020). Clonal haematopoiesis in chronic ischaemic heart failure: prognostic role of clone size for DNMT3A- and TET2-driver gene mutations. European Heart Journal. 42(3). 257–265. 106 indexed citations

Cremer, Sebastian, Evangelia Pardali, Khalil Abou‐El‐Ardat, et al.. (2020). Somatic blood cell mutations at low variant allele frequency in distinct risk genes are associated with increased mortality in patients with chronic ischemic heart failure. European Heart Journal. 41(Supplement_2). 1 indexed citations

Conde, Marina Clemente, Mirko Peitzsch, Susan Richter, et al.. (2019). Mutant IDH1 Differently Affects Redox State and Metabolism in Glial Cells of Normal and Tumor Origin. Cancers. 11(12). 2028–2028. 24 indexed citations

Dorsheimer, Lena, Birgit Aßmus, Tina Rasper, et al.. (2018). Association of Mutations Contributing to Clonal Hematopoiesis With Prognosis in Chronic Ischemic Heart Failure. JAMA Cardiology. 4(1). 25–25. 326 indexed citations breakdown →

Zielke, Svenja, Nina Meyer, Muriel Mari, et al.. (2018). Loperamide, pimozide, and STF-62247 trigger autophagy-dependent cell death in glioblastoma cells. Cell Death and Disease. 9(10). 994–994. 52 indexed citations

10.

Abou‐El‐Ardat, Khalil, Michael Seifert, Kerstin Becker, et al.. (2016). Comprehensive molecular characterization of multifocal glioblastoma proves its monoclonal origin and reveals novel insights into clonal evolution and heterogeneity of glioblastomas. Neuro-Oncology. 19(4). 546–557. 78 indexed citations

11.

Moreels, Marjan, Roel Quintens, Khalil Abou‐El‐Ardat, et al.. (2014). Chronic exposure to simulated space conditions predominantly affects cytoskeleton remodeling and oxidative stress response in mouse fetal fibroblasts. International Journal of Molecular Medicine. 34(2). 606–615. 37 indexed citations

12.

Harakeh, Steve, Mona Diab‐Assaf, Rania Azar, et al.. (2014). Epigallocatechin-3-gallate Inhibits Tax-dependent Activation of Nuclear Factor Kappa B and of Matrix Metalloproteinase 9 in Human T-cell Lymphotropic Virus-1 Positive Leukemia Cells. Asian Pacific Journal of Cancer Prevention. 15(3). 1219–1225. 17 indexed citations

13.

Seifert, Michael, et al.. (2014). Autoregressive Higher-Order Hidden Markov Models: Exploiting Local Chromosomal Dependencies in the Analysis of Tumor Expression Profiles. PLoS ONE. 9(6). e100295–e100295. 20 indexed citations

14.

Abou‐El‐Ardat, Khalil, Karol Szafranski, Andreas Rump, et al.. (2013). Novel CIC Point Mutations and an Exon-Spanning, Homozygous Deletion Identified in Oligodendroglial Tumors by a Comprehensive Genomic Approach Including Transcriptome Sequencing. PLoS ONE. 8(9). e76623–e76623. 15 indexed citations

15.

Gérard, A, Sylvie Poncin, Hanane Derradji, et al.. (2012). Iodine-Deficiency-Induced Long Lasting Angiogenic Reaction in Thyroid Cancers Occurs Via a Vascular Endothelial Growth Factor–Hypoxia Inducible Factor-1–Dependent, But Not a Reactive Oxygen Species–Dependent, Pathway. Thyroid. 22(7). 699–708. 17 indexed citations

16.

Grosse, Johannes, Markus Wehland, Jessica Pietsch, et al.. (2012). Gravity‐sensitive signaling drives 3‐dimensional formation of multicellular thyroid cancer spheroids. The FASEB Journal. 26(12). 5124–5140. 71 indexed citations

17.

Gérard, A, Sylvie Poncin, Hanane Derradji, et al.. (2012). Iodine deficiency-induced long lasting angiogenic reaction in thyroid cancers occurs via a VEGF-HIF-1, but not a ROS dependent pathway.. Thyroid. 2285199234–2285199234. 2 indexed citations

18.

Abou‐El‐Ardat, Khalil, Pieter Monsieurs, Nataša Anastasov, et al.. (2011). Low dose irradiation of thyroid cells reveals a unique transcriptomic and epigenetic signature in RET/PTC-positive cells. Mutation research. Fundamental and molecular mechanisms of mutagenesis. 731(1-2). 27–40. 21 indexed citations

19.

Abou‐El‐Ardat, Khalil. (2011). Response to low-dose X-irradiation is p53-dependent in a papillary thyroid carcinoma model system. International Journal of Oncology. 39(6). 1429–41. 5 indexed citations

20.

Derradji, Hanane, Sofie Bekaert, Tim De Meyer, et al.. (2008). Ionizing radiation-induced gene modulations, cytokine content changes and telomere shortening in mouse fetuses exhibiting forelimb defects. Developmental Biology. 322(2). 302–313. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact